{"id":483,"date":"2015-08-13T00:50:49","date_gmt":"2015-08-13T04:50:49","guid":{"rendered":"https:\/\/medicarereport.org\/?p=483"},"modified":"2015-08-12T18:52:24","modified_gmt":"2015-08-12T22:52:24","slug":"african-americans-most-likely-to-stop-taking-meds-in-medicare-part-ds-coverage-gap","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=483","title":{"rendered":"African-Americans most likely to stop taking meds in Medicare Part D\u2019s coverage gap"},"content":{"rendered":"<p>(By &#8211; Bert Gambini,\u00a0www.buffalo.edu)<\/p>\n<p>Medicare Part D provides help to beneficiaries struggling with the cost of prescriptions drugs, but the plan\u2019s coverage gap hits some populations harder than others, particularly African-Americans age 65 and older. Reaching, or even approaching, the gap affects access to medication and influences whether those medications are taken as prescribed.\u00a0\u201cDon\u2019t assume that the existence of Part D means that people aren\u2019t having a difficult time affording their meds,\u201d says Louanne Bakk, an assistant professor in the University at Buffalo School of Social Work. \u201cThere are certain groups that continue struggling with prescription drug costs regardless of this federal benefit being in place.\u201d <a href=\"http:\/\/www.buffalo.edu\/news\/releases\/2015\/08\/013.html\" target=\"_blank\">Read more&#8230;<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Notice<\/strong>: The \u201c<strong>Read more<\/strong>\u2026\u201d link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By &#8211; Bert Gambini,\u00a0www.buffalo.edu) Medicare Part D provides help to beneficiaries struggling with the cost of prescriptions drugs, but the<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-483","post","type-post","status-publish","format-standard","hentry","category-medicare-general"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=483"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/483\/revisions"}],"predecessor-version":[{"id":484,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/483\/revisions\/484"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}